{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:28:51Z","timestamp":1787009331473,"version":"build-2736575974"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Aseptic meningitis is a clinical syndrome of meningeal inflammation without clear infectious aetiology. Drug-induced aseptic meningitis is a well-documented but poorly understood side effect of a variety of medications, and has rarely been described with the immunosuppressive and anti-inflammatory drug sulfasalazine. This report describes the case of a man in his 60s presenting with aseptic meningitis after commencing sulfasalazine for seronegative arthritis 1 month prior. Analysis of cerebrospinal fluid showed a predominantly mononuclear leucocytosis, slightly elevated protein, and normal glucose. Cerebrospinal fluid microscopy, culture, sensitivities, and polymerase chain reaction testing were negative for bacterial and viral causes of meningitis. The patient improved with cessation of sulfasalazine. Antimicrobial treatment was ceased with ongoing resolution of symptoms, supporting a diagnosis of sulfasalazine-induced aseptic meningitis. Clinicians should consider a diagnosis of sulfasalazine-induced aseptic meningitis when other aetiologies of meningitis have been excluded, particularly in the first weeks to months of commencing sulfasalazine.<\/jats:p>","DOI":"10.1093\/mrcr\/rxag071","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:00:33Z","timestamp":1783598433000},"source":"Crossref","is-referenced-by-count":1,"title":["Sulfasalazine-induced aseptic meningitis"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6162-0825","authenticated-orcid":false,"given":"Emily","family":"McHale","sequence":"first","affiliation":[{"name":"Department of General Medicine, Sir Charles Gairdner Hospital , Nedlands, WA ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0172-7872","authenticated-orcid":false,"given":"Andrew","family":"Dermawan","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Sir Charles Gairdner Hospital , Nedlands, WA ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sir Charles Gairdner Hospital , Nedlands, WA ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Redgrave","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Sir Charles Gairdner Hospital , Nedlands, WA ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"2026072715195781000_ref1","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2165\/00003495-200565130-00008","article-title":"Sulfasalazine: a review of its use in the management of rheumatoid arthritis","volume":"65","author":"Plosker","year":"2005","journal-title":"Drugs"},{"key":"2026072715195781000_ref2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijwd.2020.01.009","article-title":"Sulfasalazine in dermatology: a lesser explored drug with broad therapeutic potential","volume":"6","author":"Mushtaq","year":"2020","journal-title":"Int J Womens Dermatol"},{"key":"2026072715195781000_ref3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/fcp.12349","article-title":"Drug-induced aseptic meningitis: a mini-review","volume":"32","author":"Yelehe-Okouma","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"key":"2026072715195781000_ref4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.neurol.2019.07.005","article-title":"Aseptic meningitis","volume":"175","author":"Tattevin","year":"2019","journal-title":"Rev Neurol (Paris)"},{"key":"2026072715195781000_ref5","doi-asserted-by":"crossref","first-page":"e941623","DOI":"10.12659\/AJCR.941623","article-title":"Sulfasalazine-induced delayed hypersensitivity reaction presenting as fever, aseptic meningitis, and mesenteric panniculitis in a patient with seronegative arthritis","volume":"24","author":"Ng","year":"2023","journal-title":"Am J Case Rep"},{"key":"2026072715195781000_ref6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4212\/cjhp.3218","article-title":"Sulfasalazine-induced aseptic meningitis","volume":"75","author":"Bates","year":"2022","journal-title":"Can J Hosp Pharm"},{"key":"2026072715195781000_ref7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2515\/therapie\/2013065","article-title":"Sulfasalazine-induced aseptic meningitis with positive rechallenge: a case report and review of the literature","volume":"68","author":"Salouage","year":"2013","journal-title":"Therapie"},{"key":"2026072715195781000_ref8","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1111\/j.1756-185X.2012.01705.x","article-title":"Sulphasalazine-induced aseptic meningitis with facial and nuchal edema in a patient with spondyloarthritis","volume":"15","author":"Tay","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"2026072715195781000_ref9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jbspin.2008.08.006","article-title":"Salazopyrine-induced aseptic meningitis","volume":"76","author":"Houitte","year":"2009","journal-title":"Joint Bone Spine"},{"key":"2026072715195781000_ref10","first-page":"409","article-title":"Sulfasalazine neurotoxicity: a report of aseptic meningitis and a review of the literature","volume":"20","author":"Alloway","year":"1993","journal-title":"J Rheumatol"},{"key":"2026072715195781000_ref11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/ard.50.9.645","article-title":"Meningitis associated with sulphasalazine in a patient with Sj\u00f6gren\u2019s syndrome and polyarthritis","volume":"50","author":"Merrin","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"2026072715195781000_ref12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"2026072715195781000_ref13","first-page":"1","article-title":"A rare complication of trimethoprim-sulfamethoxazole: drug induced aseptic meningitis","volume":"2016","author":"Jha","year":"2016","journal-title":"Case Rep Infect Dis"},{"key":"2026072715195781000_ref14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000312632","article-title":"Cross-reactivity in drug hypersensitivity reactions to sulfasalazine and sulfamethoxazole","volume":"153","author":"Zawodniak","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"2026072715195781000_ref15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.anai.2014.08.006","article-title":"Trimethoprim-sulfamethoxazole-induced aseptic meningitis \u2013 not just another sulfa allergy","volume":"113","author":"Bruner","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026072715195781000_ref16","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxag071\/68754499\/rxag071.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/2\/rxag071\/68754499\/rxag071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/2\/rxag071\/68754499\/rxag071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:20:07Z","timestamp":1785180007000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxag071\/8731888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6,29]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxag071","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"rxag071"}}